VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (5968)	11/18/1998 9:05:00 AM
From: Henry Niman	Read Replies (1) of 9719

I believe that the protocol called for application to the KS lesion only and the drug is not systemically absorbed so there should not be data on other types of lesions. Panretin oral has been used in a psoriasis trial and results are expected to be released when the Targretin oral trial is completed..

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next